Cardiovascular Coalition
Coalition to advance patient access to community-based care for peripheral artery disease
Based in DC
🤖
AI Overview
With $3.1M in lobbying spend across 29 quarterly filings, Cardiovascular Coalition is a significant lobbying presence.
$3.1M
Total Lobbying Spend
29
Quarterly Filings
1
Lobbying Firms Used
4
Individual Lobbyists
Spending by Year
| Year | Lobbying Spend |
|---|---|
| 2018 | $270K |
| 2019 | $400K |
| 2020 | $410K |
| 2021 | $370K |
| 2022 | $440K |
| 2023 | $430K |
| 2024 | $430K |
| 2025 | $330K |
Lobbying Firms
LIBERTY PARTNERS GROUP, LLC
What They Lobby For
- Medicare physician payment and policy issues relating to peripheral arterial disease.
- Physician payment and policy issues relating to peripheral arterial disease.
- Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues.
- Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; Elective surgery guidance relating to COVID-19 pandemic.
- Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; Elective surgery guidance relating to COVID-19 pandemic; E/M budget neutrality under the Physician Fee Schedule.
- Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; E/M budget neutrality under the Physician Fee Schedule.
- Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; E/M budget neutrality under the Physician Fee Schedule; Amputation Reduction and Compassion Act.
- Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; S.610 - Protecting Medicare and American Farmers from Sequester Cuts Act; H.R.6048 - Medicare Stability for Patients and Providers Act; Amputation Reduction and Compassion Act.
- Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; Amputation Reduction and Compassion Act, H.R. 2631.
- Physician payment and policy issues relating to peripheral arterial disease and other cardiovascular issues; Amputation Reduction and Compassion Act, H.R. 2631; H.R. 8800, Supporting Medicare Providers Act of 2022.
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Federal Lobbying Statistics 2025
The definitive stats — $15.2B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.